News

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
Scientific American14h
Why mRNA Vaccines Are So Revolutionary—And What’s at Stake if We Lose Them
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
What to know about mRNA vaccines
WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...
CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech
(Reuters) -German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long ...
UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants
There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
Moderna Announces Data to be Presented at ESMO Congress 2025
CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...
New research using mRNA vaccines targets rare cancers
Founder of the Medulloblastoma Initiative, Fernando Goldsztein, discusses the new MBI-funded research on experimental mRNA ...
US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...